Microfluidic-Chip-Integrated Biosensors for Lung Disease Models
Lung diseases (e.g., infection, asthma, cancer, and pulmonary fibrosis) represent serious threats to human health all over the world. Conventional two-dimensional (2D) cell models and animal models cannot mimic the human-specific properties of the lungs. In the past decade, human organ-on-a-chip (OO...
Main Authors: | Shuang Ding, Haijun Zhang, Xuemei Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-11-01
|
Series: | Biosensors |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6374/11/11/456 |
Similar Items
-
Biosensors-on-Chip: An Up-to-Date Review
by: Cristina Chircov, et al.
Published: (2020-12-01) -
Microfluidic Gut-on-a-Chip: Fundamentals and Challenges
by: Dimple Palanilkunnathil Thomas, et al.
Published: (2023-01-01) -
Recent Progress in PDMS-Based Microfluidics Toward Integrated Organ-on-a-Chip Biosensors and Personalized Medicine
by: Fahad Alghannam, et al.
Published: (2025-01-01) -
Microfluidic Liver-on-a-Chip for Preclinical Drug Discovery
by: Jingyu Fu, et al.
Published: (2023-04-01) -
Microfluidics Integrated Biosensors: A Leading Technology towards Lab-on-a-Chip and Sensing Applications
by: George Luka, et al.
Published: (2015-12-01)